A shortage of IV fluid in the wake of Hurricane Helene is shining a spotlight on the fragility and vulnerability of the ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

WEDNESDAY, Oct. 16, 2024 (HealthDay News) -- Following hurricane damage that shuttered a North Carolina plant that makes 60% ...

Patients with inflammatory bowel disease (IBD) who initially responded to the investigational monoclonal antibody ...

The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after ...

As a long-term holding, Pfizer should benefit from demographic trends driving increased healthcare spending globally. The ...

The Therapeutic Goods Administration has given Pfizer's new COVID-19 jab the green light. But what about vaccines from ...

Baby Boomers looking to put new money to work may wish to check out the broader basket of dividend stocks while interest ...

The new COVID vaccine is here, but does it bring any new side effects or reactions? Here's what the COVID booster 2024 side ...

The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.

A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...

Bernstein said Thursday it has started research coverage of US biopharma stocks, voicing a positive outlook for the sector.